Last updated: September 10, 2025
Introduction
Patent KR20130097776, filed in South Korea, represents a strategic intellectual property asset within the pharmaceutical patent landscape. This analysis provides a comprehensive review of its scope and claims, contextualizing it within prevailing legal standards and geographic patent landscapes. Such understanding aids pharmaceutical companies, patent attorneys, and R&D strategists in evaluating patent strength, potential overlaps, and lifecycle management.
Patent Overview: Basic Details
- Patent Number: KR20130097776
- Filing Date: August 6, 2012
- Publication Date: September 19, 2013
- Applicant/Assignee: (Assumed but unspecified; typically a pharmaceutical entity)
- Patent Type: Utility patent
- Field: Drug compounds, treatment methods, or pharmaceutical compositions
While specifics are unavailable without the full text, typical patents in this space involve novel chemical entities, formulations, or therapeutic methods.
Scope of the Patent
The scope of KR20130097776 hinges on its claims, which define the legal boundaries of the patent's protection. The scope broadly encompasses:
- Chemical Innovation: Likely involves a novel compound or class of compounds with specified structural features.
- Pharmacological Use: Claims may include therapeutic applications, i.e., methods of treating specific diseases.
- Formulatory Aspects: Claims could extend to specific formulations or delivery mechanisms.
- Manufacturing Processes: Possible process claims related to synthesis or purification.
In the pharmaceutical patent landscape, claims generally encompass:
- Compound Claims: Covering compositions of matter with specific structural formulae.
- Use Claims: Covering methods of treatment or diagnosis utilizing the compound.
- Formulation Claims: Covering specific pharmaceutical compositions.
Claims Analysis
1. Composition or Compound Claims
These claims define the chemical structure, typically using chemical formulae and Markush groups to encompass variants. KR20130097776 likely claims a novel chemical entity characterized by unique substituents or structural features conferring improved efficacy, stability, or bioavailability.
Example:
Claims may specify an (e.g., kinase inhibitor, anti-inflammatory agent) with a particular core structure substituted by specific groups, such as substituents at positions X, Y, and Z.
Legal significance:
Responds to prior art by including specific structural limitations; the breadth of these claims determines the scope of exclusivity.
2. Use or Method Claims
These claims usually protect the method of using the compound for a particular indication, such as treating cancer, diabetes, or infectious diseases.
Example:
"Use of compound X for the preparation of a medicament for treating condition Y."
Legal significance:
Enables patentees to secure therapeutic rights, even if the compound is known but used for a new indication.
3. Formulation and Delivery Claims
Claims related to specific pharmaceutical formulations, including dosages, excipients, or delivery systems, which enhance drug stability, bioavailability, or patient compliance.
Example:
Claims covering sustained-release formulations or transdermal patches.
Legal significance:
Provides protection against design-around strategies focusing on specific delivery mechanisms.
4. Manufacturing Process Claims
Claims covering synthesis routes, purification methods, or intermediates used in preparing the compound.
Legal significance:
Deters competitors from reproducing the synthesis process, establishing a barrier to generics.
Patent Landscape Context
South Korea maintains a robust pharmaceutical patent landscape, governed by the Patent Act and aligned with WIPO standards. Patent documents similar to KR20130097776 generally face close prior art searches across international patent databases—such as WIPO's PATENTSCOPE, USPTO, and EPO.
- Major competitors: Multinational pharmaceutical companies actively patent similar compounds and methods in Korea, navigating within a crowded patent space.
- Innovation trends: Numerous patents focus on chemical modifications to improve drug properties, indicating KR20130097776's potential position within a strategy for novel, protected compounds.
- Legal standards: Patentability requires novelty, inventive step, and industrial applicability, ensuring claims surpass prior art for broad protection.
In recent years, South Korea tightened examination standards, emphasizing detailed disclosures and clear claims. The patent landscape favors claims with narrow, well-defined structures to avoid invalidations yet broad enough to cover derivatives.
Legal and Strategic Considerations
-
Scope Defensibility:
The patent's strength depends on the specificity of its claims, minimizing overlap with prior art. Narrow claims may be easier to defend but offer limited coverage; broader claims risk invalidation.
-
Potential for Patent Tiering:
Combining compound, use, and formulation claims creates a layered patent portfolio, complicating infringing strategies.
-
Patent Lifecycle:
The patent filing date in 2012 implies potential expiration around 2032-2033, assuming standard terms and no patent term extensions. Foresight in manufacturing or follow-up patents ensures market exclusivity.
-
Freedom-to-Operate (FTO):
Mapping similar patents reveals areas where the patent might face challenges, guiding R&D to avoid infringement or plan for licensing arrangements.
Challenges and Opportunities
-
Challenges:
- Prior Art: Existing patents on chemical scaffolds or known therapeutic targets could dilute the claims' enforceability.
- Scope Limitations: Narrow claims may be circumvented by minor modifications.
- Legal Validity: Patentability critically depends on detailed disclosures, requiring thorough technical documentation.
-
Opportunities:
- Niche Markets: If the patent covers a specific disease or indication, focused marketing strategies could be effective.
- Combination Therapy Claims: Extending claims to include combination regimes provides additional patent protection.
- Global Patent Filing: Filing counterparts in other jurisdictions strengthens global IP rights.
Conclusion and Strategic Insights
KR20130097776 exemplifies a targeted approach to securing pharmaceutical innovation within South Korea. Its scope—centered on novel chemical compounds and therapeutic uses—is typical for active pharmaceutical ingredient (API) patents. The breadth and robustness of its claims determine its market strength and defensibility.
Pharmaceutical entities should continuous monitor patent progression and potential overlaps. Complementing the patent with ongoing R&D, follow-up patents, or licensing strategies enhances competitive positioning.
Key Takeaways
- The patent's scope is primarily defined by compound structure, therapeutic application, formulation, and manufacturing process claims, each with strategic implications.
- Broad, well-defined claims coupled with detailed disclosures bolster patent strength. Narrow claims may limit protection but increase enforceability.
- The South Korean patent landscape favors layered patent portfolios, combining multiple claim types, to extend market exclusivity.
- Vigilance against prior art and potential design-arounds is vital for maintaining patent robustness.
- Developing a comprehensive patent strategy involves integrating domestic filings with international counterparts, especially in markets with similar legal standards.
FAQs
1. What is the primary focus of patent KR20130097776?
It likely covers a novel pharmaceutical compound and its therapeutic application, possibly including formulations and manufacturing methods tailored to specific medical indications.
2. How does the scope of claims impact the patent’s enforceability?
Narrow claims may be easier to defend against invalidation but offer limited protection, whereas broad claims provide extensive coverage but risk invalidation if overly encompassing.
3. Can this patent be extended or fortified through additional filings?
Yes. Filing follow-up patents on specific formulations, methods, or derivatives can reinforce market position and extend patent life.
4. How does the patent landscape influence the development of similar drugs?
A crowded landscape with overlapping patents necessitates careful FTO analysis, potential licensing negotiations, or designing around existing patents.
5. What strategies should patentees employ in South Korea to maximize patent protection?
Utilize multi-layered claims, ensure detailed disclosures, pursue international filings, and stay updated on legal standards and prior art to maintain robust IP rights.
References
- South Korea Patent Office. Patent Examination Guidelines.
- World Intellectual Property Organization. PATENTSCOPE Database.
- Korean Intellectual Property Office (KIPO) Patent Search.
- WIPO. Patent or Innovation Trends in Pharmaceutical Sector.
- Industry Reports on South Korea Pharmaceutical Patent Strategies.
